Sama Chemo Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 21-12-2024
- Paid Up Capital ₹ 2.42 M
as on 21-12-2024
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.20 Cr
as on 21-12-2024
- Satisfied Charges ₹ 3.12 Cr
as on 21-12-2024
- Revenue 19.28%
(FY 2020)
- Profit 81.93%
(FY 2020)
- Ebitda 144.41%
(FY 2020)
- Net Worth 9.46%
(FY 2020)
- Total Assets 7.78%
(FY 2020)
About Sama Chemo Pharma
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.42 M.
The company currently has active open charges totaling ₹1.20 Cr. The company has closed loans amounting to ₹3.12 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sarjerao Yadav and Madhuri Yadav serve as directors at the Company.
- CIN/LLPIN
U24231PN2004PTC019760
- Company No.
019760
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Sangli, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sama Chemo Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarjerao Yadav  | Managing Director | 20-Sep-2004 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhuri Yadav | Director | 20-Sep-2004 | Current |
Financial Performance of Sama Chemo Pharma.
Sama Chemo Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 19.28% increase. The company also saw a substantial improvement in profitability, with a 81.93% increase in profit. The company's net worth moved up by a moderate rise of 9.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sama Chemo Pharma?
In 2019, Sama Chemo Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sama Industries And Engineering Private LimitedActive 9 years 1 monthSarjerao Yadav and Madhuri Yadav are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Jul 2019 | ₹1.20 Cr | Open |
Union Bank Of India Creation Date: 03 Nov 2012 | ₹1.60 M | Satisfied |
Axis Bank Limited Creation Date: 22 Aug 2007 | ₹1.48 Cr | Satisfied |
How Many Employees Work at Sama Chemo Pharma?
Unlock and access historical data on people associated with Sama Chemo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sama Chemo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sama Chemo Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
